Maryland House Bill 517 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 1 2023 - 25% progression, died in chamber
Action: 2023-03-17 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]

Requiring manufacturers of certain drugs to operate a certain drug take-back program or enter into a certain agreement with a drug take-back organization or the Maryland Department of Health, in conjunction with the Department of the Environment; requiring the Maryland Department of Health, in conjunction with the Department of the Environment, to determine whether a drug take-back program complies with certain requirements and to provide notification of its determination within a certain time period; etc.

Drug Manufacturers - Drug Take-Back Programs (Take It Back Maryland Act)

Del. Jared Solomon [D]

Date	Chamber	Action
2023-03-17	House	Withdrawn by Sponsor
2023-02-13	House	Hearing 3/02 at 1:00 p.m.
2023-02-01	House	First Reading Health and Government Operations

SB575 (Crossfiled) 2023-03-15 - Withdrawn by Sponsor

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21	228	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0517?ys=2023RS
Text	https://mgaleg.maryland.gov/2023RS/bills/hb/hb0517f.pdf
Supplement	https://mgaleg.maryland.gov/2023RS/votes_comm/hb0517_hgo.pdf